China's First Judicial Decision on Patent Linkage

June 09, 2022 | BY

Fang Qi &Danlei Wu

The Beijing Intellectual Property Court recently issued the first-ever decision in a dispute between a brand-name and a generic drug company under China's newly-created patent linkage regime. Fang Qi and Danlei Wu of Fangda Partners examine the decision and its implications

 

Summary 

  • China has recently introduced a patent linkage regime which aims to resolve patent disputes more quickly.
  • This regime was tested recently in a dispute between a brand-name and a generic drug company which was decided on by the Beijing IP Court.
  • Patent linkage lawsuits can be started with declarations being filed at either the Beijing IP Court or the CNIPA – each forum has certain advantages.
  • It will take some time for details of the regime to be ironed out, and guidance is expected to be issued in due course. This is likely to result in a rise in the number of patent linkage cases.

 

 

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]